Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis-Reference-Cited by-同舟云学术

Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis

Published:2022-11 Issue:11 Volume:31 Page:106798
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Yan Yu,Hao Ruixiao,Zhao Xiuyuan,Xia Xiaoshuang,Wang Lin,Li Xin

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Rehabilitation,Surgery

Reference31 articles.

1. Antiplatelet therapy in secondary ischemic stroke prevention - a short review;Florescu;Rom J Morphol Embryol,2019

2. Global burden of stroke;Katan;Semin Neurol,2018

3. Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials;Barbarawi;J Community Hosp Intern Med Perspect,2019

4. Role of CYP2C19 alleles in the management of recurrent ischemic stroke;Lyerly;Neurol Clin Pract,2019

5. High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: systematic review and meta-analysis;Alakbarzade;J Stroke Cerebrovasc Dis,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort study;Thrombosis Research;2024-04

2. Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies;Cardiovascular Drugs and Therapy;2023-12-01